• Product nameAnti-LIS1 antibody [EPR3335(2)]
    See all LIS1 primary antibodies
  • Description
    Rabbit monoclonal [EPR3335(2)] to LIS1
  • Tested applicationsSuitable for: IP, WB, Flow Cytmore details
    Unsuitable for: ICC or IHC-P
  • Species reactivity
    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide corresponding to residues in Human LIS1.

  • Positive control
    • Human fetal brain, HeLa, SH-SY5Y, and 293T cell lysates, HeLa cells
  • General notes

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.


  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
  • Storage bufferPBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%
  • PurityTissue culture supernatant
  • ClonalityMonoclonal
  • Clone numberEPR3335(2)
  • IsotypeIgG
  • Research areas


Our Abpromise guarantee covers the use of ab109630 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IP 1/10 - 1/100.
WB 1/1000 - 1/10000. Predicted molecular weight: 47 kDa.
Flow Cyt 1/1000 - 1/10000. ab172730-Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
  • Application notesIs unsuitable for ICC or IHC-P.
  • Target

    • FunctionRequired for proper activation of Rho GTPases and actin polymerization at the leading edge of locomoting cerebellar neurons and postmigratory hippocampal neurons in response to calcium influx triggered via NMDA receptors. Non-catalytic subunit of an acetylhydrolase complex which inactivates platelet-activating factor (PAF) by removing the acetyl group at the SN-2 position (By similarity). Positively regulates the activity of the minus-end directed microtubule motor protein dynein. May enhance dynein-mediated microtubule sliding by targeting dynein to the microtubule plus end. Required for several dynein- and microtubule-dependent processes such as the maintenance of Golgi integrity, the peripheral transport of microtubule fragments and the coupling of the nucleus and centrosome. Required during brain development for the proliferation of neuronal precursors and the migration of newly formed neurons from the ventricular/subventricular zone toward the cortical plate. Neuronal migration involves a process called nucleokinesis, whereby migrating cells extend an anterior process into which the nucleus subsequently translocates. During nucleokinesis dynein at the nuclear surface may translocate the nucleus towards the centrosome by exerting force on centrosomal microtubules. May also play a role in other forms of cell locomotion including the migration of fibroblasts during wound healing.
    • Tissue specificityFairly ubiquitous expression in both the frontal and occipital areas of the brain.
    • Involvement in diseaseDefects in PAFAH1B1 are the cause of lissencephaly type 1 (LIS1) [MIM:607432]; also known as classic lissencephaly. LIS1 is characterized by agyria or pachgyria and disorganization of the clear neuronal lamination of normal six-layered cortex. The cortex is abnormally thick and poorly organized with 4 primitive layers. LIS1 is associated with enlarged and dysmorphic ventricles and often hypoplasia of the corpus callosum.
      Defects in PAFAH1B1 are the cause of subcortical band heterotopia (SBH) [MIM:607432]. SBH is a mild brain malformation of the lissencephaly spectrum. It is characterized by bilateral and symmetric ribbons of gray matter found in the central white matter between the cortex and the ventricular surface.
      Defects in PAFAH1B1 are a cause of Miller-Dieker lissencephaly syndrome (MDLS) [MIM:247200]. MDLS is a contiguous gene deletion syndrome of chromosome 17p13.3, characterized by classical lissencephaly and distinct facial features. Additional congenital malformations can be part of the condition.
    • Sequence similaritiesBelongs to the WD repeat LIS1/nudF family.
      Contains 1 LisH domain.
      Contains 7 WD repeats.
    • DomainDimerization mediated by the LisH domain may be required to activate dynein.
    • Cellular localizationCytoplasm > cytoskeleton. Cytoplasm > cytoskeleton > centrosome. Cytoplasm > cytoskeleton > spindle. Nucleus membrane. Redistributes to axons during neuronal development. Also localizes to the microtubules of the manchette in elongating spermatids and to the meiotic spindle in spermatocytes (By similarity). Localizes to the plus end of microtubules and to the centrosome. May localize to the nuclear membrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • LIS 1 antibody
      • LIS 2 antibody
      • LIS-1 antibody
      • LIS1 antibody
      • LIS1_HUMAN antibody
      • LIS2 antibody
      • Lissencephaly 1 protein antibody
      • Lissencephaly-1 protein antibody
      • MDCR antibody
      • MDS antibody
      • PAF acetylhydrolase 45 kDa subunit antibody
      • PAF AH 45 kDa subunit antibody
      • PAF AH alpha antibody
      • PAF-AH 45 kDa subunit antibody
      • PAF-AH alpha antibody
      • PAFAH alpha antibody
      • PAFAH antibody
      • PAFAH1B1 antibody
      • PAFAHA antibody
      • Platelet activating factor acetylhydrolase 1b regulatory subunit 1 antibody
      • Platelet activating factor acetylhydrolase isoform Ib alpha subunit antibody
      • Platelet-activating factor acetylhydrolase IB subunit alpha antibody
      see all

    Anti-LIS1 antibody [EPR3335(2)] images

    • Overlay histogram showing SHSY-5Y cells stained with ab109630 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab109630, 1/10000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in SHSY-5Y cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
    • All lanes : Anti-LIS1 antibody [EPR3335(2)] (ab109630) at 1/1000 dilution

      Lane 1 : Human fetal brain lysate
      Lane 2 : HeLa cell lysate
      Lane 3 : SH-SY5Y cell lysate
      Lane 4 : 293T cell lysate

      Lysates/proteins at 10 µg per lane.

      Predicted band size : 47 kDa
    • Flow cytometric analysis of permeabilized HeLa cells using ab109630 at a dilution of 1/10 (red) or a rabbit IgG (negative) (green).

    References for Anti-LIS1 antibody [EPR3335(2)] (ab109630)

    ab109630 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab109630.
    Please use the links above to contact us or submit feedback about this product.